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Abstract 
Assembling multiple DNA fragments into functional plasmids is an important and 
often rate-limiting step in engineering new functions in living systems. Bacteriophage 
integrases are enzymes that carry out efficient recombination reactions between short 
defined DNA sequences known as att sites. These DNA splicing reactions can be used 
to assemble large numbers of DNA fragments into a functional circular plasmid in a 
method termed serine integrase recombinational assembly (SIRA). The resulting 
DNA assemblies can easily be modified by further recombination reactions catalyzed 
by the same integrase in the presence of its recombination directionality factor (RDF). 
Here we present a set of protocols for the over-expression and purification of 
bacteriophage C31 and Bxb1 integrase and RDF proteins, their use in DNA 
assembly reactions, and subsequent modification of the resulting DNA assemblies. 
Keywords 
Site-specific recombination, DNA assembly, Large serine integrase, bacteriophage 
C31, synthetic biology, metabolic engineering. 
 
1. Introduction 
Site-specific recombinases are enzymes that cut and rejoin DNA sequences at short 
defined DNA sites [1-4]. One class of site-specific recombinases, the bacteriophage 
serine integrases, function in nature to integrate circular bacteriophage DNA into their 
host genomes [5]. These enzymes catalyze recombination between short (~50 bp) attP 
sites on the phage DNA and (~40 bp) attB sites on the bacterial genome. The product 
sites, each comprising one half of attP joined to one half of attB, are known as attL 
and attR (Figure 1A). Recombination between attP and attB can be reconstituted in 
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vitro using purified integrase protein and DNA substrates [6,7]. Integrase is the only 
protein required for recombination. The reaction is highly efficient and unidirectional; 
the product sites (attL and attR) do not undergo further recombination reactions in the 
presence of integrase alone. However, in the presence of a second protein, the 
bacteriophage-encoded recombination directionality factor (RDF), integrase catalyzes 
efficient recombination between attL and attR to recreate attP and attB [8,9] (Figure 
1A). 
Recombination sites (for example C31 attP and attB; Figure 1B) can easily 
be added to the ends of DNA fragments by PCR using primers that incorporate the 
desired sites. Any DNA fragment containing an attP site can be efficiently joined to a 
second DNA fragment containing an attB site in a recombination reaction promoted 
by integrase in a simple buffer [10]. The two DNA fragments will be separated by an 
attL site, and a small DNA fragment containing attR will be released (Figure 1C). To 
join a series of DNA fragments together in a defined order, attP-attB pairs that 
recombine only with each other are required. Serine integrases cleave their DNA att 
sites centrally, leaving 2-nucleotide overhanging ends that must be complementary for 
efficient recombination [10]. Thus pairs of sites can be created with different 2-bp 
central dinucleotide sequences, which will only recombine with each other. Six 
different asymmetric dinucleotides can be used to create six orthogonal pairs of att 
sites (Figure 1D) [10]. Integrases from different bacteriophage recognize and 
recombine only their own specific attP and attB sites, thus further pairs of 
“orthogonal” att sites can be created by using sites and recombinases from different 
bacteriophage. In our experiments with C31 and Bxb1 integrases, we have found no 
detectable difference in recombination efficiency between att sites with different 
central dinucleotides, though we have found difference between different integrases. 
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When engineering DNA assemblies to create new biological functions, it is 
often necessary to modify just one part of the assembly as part of a design-build-test-
redesign cycle. The DNA assemblies produced using SIRA contain multiple DNA 
fragments joined together end-to-end, with each fragment separated from the next by 
an attL site. Assemblies can therefore be modified by further targeted reactions with 
integrase and RDF, using DNA fragments containing attR sites that can recombine 
only with specific attL sites in the assembly. 
In this chapter we provide detailed protocols for over-expressing large serine 
integrases and their RDFs from two different bacteriophage, C31 and Bxb1. We then 
give protocols for multipart DNA assembly using these phage integrases. We include 
design considerations and detailed instructions for adding att sites to linear DNA 
fragments by PCR. Finally we give a protocol for modifying SIRA assemblies by 
further attL x attR recombination reactions in the presence of integrase and RDF 
proteins. 
2. Materials 
Ultrapure (double-distilled) water (ddH2O) is used to make up solutions for protein 
purification and DNA biochemistry. De-ionized water can be used to prepare growth 
media and gel running buffers. Bacterial media are sterilized at 121°C for 20 minutes. 
2.1 Bacterial strains 
1. E. coli TOP10: F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG 
recA1 araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 λ-. For 
routine plasmid isolation and growth. 
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2. E. coli DB3.1: F- gyrA462 endA1 glnV44 Δ(sr1-recA) mcrB mrr hsdS20(rB-, 
mB-) ara14 galK2 lacY1 proA2 rpsL20(Strr) xyl5 Δleu mtl1. For maintaining 
SIRA vectors containing the toxic ccdB gene. 
3. E. coli BL21(DE3) pLysS: E. coli strain B, F- ompT gal dcm lon hsdSB(rB-mB-) 
λ(DE3 [lacI lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-12(λS) pLysS[T7p20 
orip15A](CmR). For protein expression using vectors with the T7 promoter. 
2.2 Plasmids 
1. pET28a(+): T7 expression vector (adds N-terminal His6 tag to encoded 
proteins). 
2. pARM010: pET-28a(+)-based expression plasmid for C31 integrase with an 
N-terminal His6 tag [11]. 
3. pEY301 expression plasmid for C31 RDF (gp3) with an N-terminal His6 tag 
[9]. 
4. pFM12: pET-28a(+)-based expression plasmid for Bxb1 integrase with a C-
terminal His6 tag  [12]. 
5. pFM13: pET-28a(+)-based expression plasmid for Bxb1 RDF (gp47) with an 
N-terminal His6 tag [12]. 
6. pSIRA1: AmpR oripMB1 vector with C31 attP sites flanking the conditionally 
lethal ccdB gene [10]. 
7. pSIRA10: AmpR oripMB1 vector with Bxb1 attP sites flanking the conditionally 
lethal ccdB gene. 
8. p-ccdB-CmR: P1004 chloramphenicol resistance biobrick and P1010 ccdB 
biobrick in pSB1A3 [10]. 
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2.3 Growth media 
1. Lysogeny broth (LB): 10 g tryptone, 5 g yeast extract, 10 g NaCl made up to 1 
litre with deionized water and autoclaved at 121 °C for 20 minutes. 
2. LB agar: add 15 g/L agar to LB broth prior to autoclaving 
3. 2x YT broth: 16 g tryptone, 10 g yeast extract, 5 g NaCl made up to 1 litre 
with deionized water and autoclaved at 121 °C for 20 minutes. 
4. 50 mM CaCl2 solution. Sterilized at 121 °C for 20 minutes. 
5. Ampicillin stock solution (1000 x): 100 mg/ml in sterile water 
6. Kanamycin stock solution (1000 x): 25 mg/ml in sterile water  
7. Chloramphenicol stock solution (1000 x): 25 mg/ml in100% ethanol. (Note 1)  
8. IPTG solution: 100 mM isopropyl-β-D-thiogalactoside (IPTG) in sterile water. 
This stock solution can be stored for several months at -20 °C. 
2.4 Buffers and solutions for protein purification 
1. Pellet Wash Buffer (PWB): 20 mM Tris-HCl, pH 7.5, 10 mM MgCl2. 
2. PMSF solution: 100 mM in 100% ethanol. (This solution should be prepared 
fresh just before use). 
3. Buffer A: 20 mM sodium phosphate, pH 7.4, 1 M NaCl, 1 mM dithiothreitol, 
50 mM imidazole (for cell lysis and column loading). Prepare by mixing 32.4 
ml 500 mM NaH2PO4, 7.6 ml 500 mM Na2HPO4, 250 ml 4 M NaCl, 1 ml 1 M 
dithiothreitol, 50 ml 1 M imidazole, and making up to 1 litre with ddH2O. 
Filter and degas by passing using a 0.22 m vacuum filter. 
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4. Buffer B: 20 mM sodium phosphate, pH 7.4, 1 M NaCl, 1 mM dithiothreitol, 
500 mM imidazole (for elution from the nickel column). Make up as for 
Buffer A, but use 500 ml of 1 M imidazole. Filter through a 0.22 m vacuum 
filter. 
5. Recombinase Dialysis/Dilution Buffer (RDB): 25 mM Tris-HCl, pH 7.5, 1 M 
NaCl, 1 mM DTT, 50% glycerol. 
2.5 Buffers for SIRA reactions 
1. TE0.1: 10 mM Tris-HCl pH, 8.0, 0.1 mM EDTA. 
2. 2 mM dNTP solution: 2 mM dATP, 2 mM dCTP, 2 mM dGTP, 2 mM dTTP 
in ddH2O. 
3. 4 x assembly buffer: 40 mM Tris–HCl, pH 7.5, 20 mM spermidine·3HCl, 0.4 
mM EDTA, 0.4mg/ml bovine serum albumin. 
4. 20 mM dithiothreitol (DTT). 
5. Tris Acetate EDTA (TAE) gel running buffer: 40 mM Tris base, 20 mM acetic 
acid, 1 mM EDTA. Prepare a 50 x stock by dissolving 242 g Tris base and 
18.61 g EDTA (disodium salt) in 700 ml deionized water. Add 57.1 ml glacial 
acetic acid and make up to 1 litre with water. Prepare gel running buffer by 
diluting stock 50-fold with water. 
6. Glycerol SDS loading dye: 30% (v/v) glycerol, 0.5 % (w/v) sodium dodecyl 
sulphate, 0.25% (w/v) bromophenol blue, 10 mM Tris-HCl pH 8.0, 1 mM 
EDTA. 
7. Ethidium bromide: 10 mg/ml in distilled water. Dilute 1 in 20,000 for gel 
staining. 
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2.6 Equipment 
1. Sonicator suitable for sonicating ~10 ml E. coli suspension. We use a Sonics 
VCX 400 ultrasonic processor with a standard 13 mm tip.  
2. Suitable container for sonication. We use a Corning 50 ml polypropylene 
centrifuge tube with the top ~ 5 cm cut off to allow entry of the sonicator 
probe. A 50 ml glass beaker can also be used. 
3. A centrifuge capable of centrifuging 200 ml tubes at 9800 g and 30 ml tubes at 
up to 48000 g. We use an Avanti J-25 centrifuge (Beckman Coulter) with a 
JA14 rotor for 200 ml tubes and a JA20 rotor for 50 ml tubes. 
4. Clean and sterile screw-capped polypropylene centrifuge tubes suitable for the 
centrifuge used. 
5. A FPLC system with pump, UV detector and fraction collector for Nickel 
affinity chromatography. We use an AKTA purifier (GE Healthcare, Uppsala, 
Sweden). Any suitable alternative FPLC setup could be used. 
6. Vacuum filters (0.22 m) that can be connected to 500 ml bottles and a 
suitable diaphragm vacuum pump. 
7. 1 ml His Trap HP pre-packed Ni-Sepharose columns (GE Healthcare) 
8. Equipment and buffers for SDS polyacrylamide gel electrophoresis. E.g. 
Biorad Mini Protean system. 
9. Slide-A-Lyzer® dialysis cassettes (Thermo Fisher) or dialysis bags and clips 
to dialyse 2-3 ml samples. 
10. PCR machine. 
11. Equipment for agarose gel electrophoresis. 
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12. Long wave UV transilluminator (365 nm) for visualizing ethidium bromide 
stained agarose gels without damaging the DNA. 
13. Qiagen QIA quick gel extraction kit (or a similar kit) for purification of DNA 
from agarose gels.  
14. QIAprep spin miniprep kit (or a similar kit) for purification of plasmid DNA 
from E. coli. 
15. Heated/cooled shaking incubator capable of maintaining cultures at 37 °C and 
20 °C . 
16. Microbiological static incubator for E. coli growth on plates at 37 °C. (Note 2)  
17. Plate drier or laminar flow hood for drying agar plates prior to spreading 
bacteria. 
18. Microcentrifuge, 1.5 ml microfuge tubes, micropipette, pipette tips, vented 
petri dishes and other equipment for routine molecular biology techniques. 
3. Methods 
3.1 Overexpression and purification of integrase and RDF proteins 
Integrase and RDF proteins are expressed in E. coli and purified using essentially the 
same procedure for both. 
1. Introduce the expression plasmid into E. coli strain BL21 (DE3) pLysS by 
calcium chloride transformation (Sections 3.5 and 3.6). Spread transformation 
reactions on LB-agar plates containing chloramphenicol (25 g/ml) to select for 
pLysS and kanamycin (50 g/ml) to select for the pET28-based expression 
plasmid. Incubate overnight at 37 °C. (Note 3)  
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2. Use a fresh single transformant colony to inoculate a starter culture in 2YT 
broth (10 ml) supplemented with kanamycin (50 g/ml) and chloramphenicol 
(25 g/ml). Grow overnight (~16 hours) at 37 °C with shaking (225 rpm). 
(Note 4) 
3. While cells are growing overnight, pre-warm 400 ml 2YT broth to 37 °C by 
incubating overnight in sterile bottles. 
4. The next day, pour the pre-warmed 2YT broth (400 ml) into sterile 2-litre 
conical flasks with gas-permeable (cotton wool or similar) plugs. Add 0.4 ml 
each of kanamycin and chloramphenicol stock solutions. Inoculate with the 
expression strain by adding 4 ml of the fresh overnight culture prepared in 
Step 3.  
5. Grow the culture at 37 °C in a suitable shaking incubator. Shake continuously 
(250 rpm), and monitor OD600 (the optical density at 600 nm) every 20-30 
minutes until it reaches 0.5−0.6. This typically takes 2-3 hours. 
6. Cool the culture rapidly to below 20 °C by placing in an ice / water bath. 
Induce protein expression by adding 2 ml of the 100 mM IPTG stock solution 
to the culture, giving a final concentration of 0.5 mM IPTG.  
7. Grow for a further 16 hours in a refrigerated shaking incubator at 20 °C, with 
continuous shaking at 250 rpm. (Note 5)  
8. To harvest the cells, centrifuge the culture at 9800 g for 10 minutes at 4 °C. 
Split the culture into two separate aliquots of 200 ml for centrifugation. Pre-
weigh the centrifuge tube(s) before transfer of the liquid culture to allow the 
wet weight of the harvested cell pellet to be determined after centrifugation. 
9. To remove residual culture media and any soluble extracellular materials, 
wash the pellets by re-suspending in 100 ml Pellet Wash Buffer (PWB). Use a 
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clean glass rod or gently pipette up and down to completely suspend the cell 
pellet. Keep the sample on ice as much as possible. (Note 6).  
10. Centrifuge at 9800 g for 10 minutes at 4 °C to re-pellet the cells. Pour away 
the supernatant. 
11. Weigh the cell pellet and then freeze at -20 °C or -70 °C for future use. 
Typically, the pellet should weigh 2-3 g. (Note 7) 
3.2 Purification of integrase and RDF proteins from cell pellets by nickel affinity 
chromatography 
1. If the pellet was frozen, thaw it in the centrifuge tube at room temperature, and 
transfer to an ice bucket as soon as the pellet is completely thawed. This and 
all subsequent steps are performed on ice. (Note 8)  
2. Add 25 ml ice-cold Buffer A to the thawed cell pellet (For a cell pellet 
weighing 2-3 g. Scale appropriately for different cell weights). Mix thoroughly 
but gently to suspend the cells into a smooth homogenous paste without 
lumps. This can be done by pipetting up and down while disrupting the cell 
pellet using a 10 ml pipette. Alternatively, use a clean glass rod to stir. Avoid 
introducing bubbles into the suspension.  
3. Transfer the cell suspension to a clean pre-cooled container suitable for 
sonication (e.g a cut-off 50 ml polypropylene tube see Section 2.6). The 
container must be narrow enough so that the cell suspension is more than 3 cm 
deep, for efficient sonication.  
4. Immerse the sonicator probe in the cell suspension to a depth of at least 1 cm 
and sonicate in short pulses until the cells are completely lysed. Keep the 
sample on ice throughout. We use 3 pulses of 20 seconds at 30% amplitude, 
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cooling for 2 minutes between each pulse. Ensure that the sonicator does not 
introduce excessive air into the lysate. Add 250 μl of 100 mM 
phenylmethylsulphonyl fluoride (PMSF) solution (to a final concentration of 
1 mM) immediately after the first sonication step, to inhibit proteases. (Note 
9) 
5. Transfer the sample to a 50-ml centrifuge tube and centrifuge at 48000 g, for 30 
minutes at 4 °C. 
6. Collect the supernatant carefully, avoiding the pellet, and transfer to a suitable 
container. Store on ice until ready to load onto the nickel affinity column. (Note 10)  
7. Ni2+ affinity column chromatography is used to purify the integrase and RDF 
proteins from the crude E. coli extracts on a standard system for protein liquid 
chromatography following the manufacturer’s instruction manual. Place one 
pump inlet in a bottle containing 500 ml of buffer A and the other pump inlet 
in a bottle containing 500 ml of buffer B. The alternative inlet to the first 
pump should be connected to a bottle of ddH2O. Run the pump wash purifier 
programme on all inlets to flush out the inlet lines. Set up the 
spectrophotometer to monitor absorbance at 215, 260, and 280 nm and then 
connect a pre-packed 1-ml HisTrap HP Ni2+ column to the system. (Note 11) 
8. Run five column volumes (i.e. 5 ml) of water through the column at a flow 
rate of 1 ml/min, to remove the preservation buffer. 
9. Pass ten column volumes (10 ml) of Buffer A (i.e. containing 50 mM 
imidazole but no added PMSF) through the column at a constant flow rate of 1 
ml/min. 
10. Just prior to loading the cell extract onto the column, filter it through a 0.22 
m cellulose acetate filter. Use a syringe filter attached to a 25 ml syringe. Fill 
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the syringe completely with supernatant from step 6, using a wide-bore needle 
to reach the bottom of the tube if necessary. Retain ~200 ul of sample for later 
analysis by SDS PAGE. Connect the syringe filter to the syringe, and filter the 
sample into a fresh container. Wear eye protection in case the syringe becomes 
disconnected and extract leaks out at high pressure. 
11. Load the filtered protein extract from step 10 onto the nickel column at a flow 
rate of 1 ml/min. Collect the flow-through and store it at -20 °C for later 
analysis by SDS-PAGE. (Note 12)  
12. Wash the column with a total of 25 ml Buffer A (or more) at a flow rate of 1 
ml/min, until a steady baseline absorbance is reached at 260 nm and 280 nm. 
13. Elute the His-tagged protein with a gradient from 50 mM to 500 mM 
imidazole. Set the pump to deliver a linear gradient from 100% Buffer A to 
100% Buffer B over 25 minutes at a flow rate of 1 ml/min. 
14. Start fraction collection (1 ml fractions) at the start of the gradient elution. 
Collect all fractions and store them on ice while samples are analysed by SDS-
PAGE. 
15. Run samples of each fraction (1-10 l) on SDS-PAGE [12] along with protein 
markers to select fractions to dialyse. Fractions that correspond to peaks with 
high A280/A260 ratio should be selected for further processing, since these are 
indicative of the presence of proteins in the fraction. If desired, pool similar 
fractions together for dialysis.  
16. Transfer selected fractions (1-3 ml) into dialysis cassettes and dialyse against 
500 ml Recombinase Dialysis/Dilution Buffer (RDB) for at least 6 hours at 4 
°C. Mix the buffer with gentle rotation (100 rpm), using a magnetic stirrer. 
Change the buffer by transferring the cassettes into fresh RDB (500 ml), and 
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dialyse for a further 6 hours at 4 °C. The volume will decrease due to the 
glycerol in the dialysis buffer.  
17. Collect the dialysed integrase or RDF solutions and store at -20 C. Proteins 
are used without removing the His6 tags. 
18. Measure A280 of protein solutions (or 1 in 10 dilutions in RDB). Zero the 
spectrophotometer using recombinase dilution buffer (RDB) as blank. 
Estimate the protein concentration using the calculated extinction coefficient 
for the protein [13].  
19. Make stock dilutions of proteins at 16 M, 8 M, 4 M and 2 M and store in 
screw-capped microfuge tubes at -20 C. (Note 13)  
3.3 Multipart SIRA assembly using C31 integrase and Bxb1 integrase 
This section describes how PCR fragments are assembled in a chosen order and 
inserted into a pSIRA vector (Figure 2A) in a one-pot assembly reaction. Suitable 
pairs of att sites are added onto the termini of DNA fragments by incorporating these 
sites at the 5’ ends of PCR primers. PCR is then carried out with a proof-reading 
thermostable polymerase. The PCR products are purified by gel electrophoresis and 
then quantitated. DNA fragments are recombined and the resulting product is 
introduced into E. coli cells by chemical transformation or electroporation. Plasmid 
DNA is prepared from the resulting colonies and plasmid structure is checked by 
restriction digestion and agarose gel electrophoresis. 
1. Decide how many DNA fragments are going to be assembled and decide on 
their order in the final plasmid construct. Based on the desired order of DNA 
fragments, decide which att sites to add onto the termini of each fragment. 
Each DNA junction is made by placing an attP site on one DNA fragment and 
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a matching attB sites on the other DNA fragment. Sites at the ends of the 
assembly must match the sites on the SIRA vector being used. To match, attP 
and attB sites must be recognized by the same integrase (C31 or Bxb1) and 
must have the same central dinucleotide. Strategies to assemble different 
numbers of fragments are shown in Figure 2B-E. Careful attention must be 
paid to the orientation of the att sites and their central dinucleotides. In 
general, each DNA fragment should contain either two attP sites, or two attB 
sites. However, to assemble an even number of fragments into a SIRA vector 
with a single integrase, one fragment must contain one attP and one attB site 
(Figure 2C). An alternative strategy is to use two different integrase to 
assemble an even number of fragments  (Figure 2E). When two att sites of the 
same type are being used on one PCR fragment (e.g. two C31 attP sites or 
two C31 attB sites), they should either both point inwards, or both point 
outwards to reduce primer self-complementarity.  
2. Use Primer3 [14] to design the portion of the primers that will be 
complementary to the DNA fragment to be amplified. These should generally 
be 20-25 nucleotides in length and have a melting temperature of 58 C - 60 
C predicted by Primer3 (Note 14). For a protein coding region, the forward 
primer should include the ATG start codon and the reverse primer should 
include the stop codon. For efficient expression in bacteria, an appropriate 
ribosome binding site (RBS) can be added at the 5’ end of this part of the 
forward primer. 
3. The final PCR primers should contain (starting from the 5’ end): 4-8 
nucleotides of random sequence so that the att sites are not too close to the 
termini; the chosen att site; a RBS in the forward primer if desired; and the 
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region complementary to the template DNA (Figure 3). The resulting primers 
are usually 70-90 nucleotides in length, and should be ordered from a 
commercial DNA synthesis company as standard de-salted single-stranded 
oligonucleotides. There is no need for extra purification steps. We routinely 
order from Integrated DNA Technologies at 100 nmole scale. 
4. Resuspend the oligonucleotides at a concentration of 100 M in TE0.1 and then 
make working stock solutions at 5 M by diluting the 100 M stock 1 in 20 in 
ddH2O. 
5. Set up one PCR reaction (50 l) for each fragment to be assembled, by mixing 
the following components (Note 15):  
10 l 5x HF buffer 
5 l 2mM dNTP solution 
1 l 50 mM MgCl2 
5 l Forward PCR primer (5 M) 
5 l Reverse PCR primer (5 M) 
1.5 l DMSO 
1 l template DNA 
22 l ddH2O 
0.5 l Phusion polymerase  
 
6. Carry out PCR using the following programme: 
98 C 1 minute (initial denaturation) 
Then 30 cycles of: 
98 C 20 seconds (denature) 
55 C 30 seconds (anneal) 
72 C 2 minutes (elongation) 
Followed by a final elongation step at 72 C for 10 minutes 
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Hold at 4 C. 
(Note 16) 
7. Check 2 l of the PCR reaction mixture by agarose gel electrophoresis. The 
PCR product should be a single band of the expected size (100-200 ng of 
DNA as estimated by ethidium staining adjacent to a marker of known 
concentration). There should be little or no primer dimer band present. Add 10 
l SDS loading dye to the remaining 48 l of each PCR reaction and run in a 
single lane of a 1% agarose gel in TAE buffer.  
8. Stain the gel using ethidium bromide (1 g/ml in TAE buffer) for 40 minutes. 
Destain the gel briefly in TAE running buffer and then visualize using long-
wave (365 nm) ultraviolet transillumination. (Note 17)  
9. Excise the bands using a scalpel and place into a pre-weighed 1.5 ml 
microcentrifuge tube. Estimate the volume of the gel chip to the nearest 10 l 
by weighing the tube again, assuming a density of 1 mg/l. 
10. Purify the DNA using a QIAquick Gel Extraction Kit according to the 
manufaturer’s instructions. Briefly: add 3 gel volumes of buffer QG and melt 
the gel at 50 C (about 10 minutes, mixing frequently), add 1 gel volume 
isopropanol, and spin the solution through a QIAquick column for 1 minute. 
Discard the flow-through and wash the column first with 1.5 ml of QG, then 
with 0.75 ml of PE, leaving the PE in the column for 5 minutes. Wash again 
with an additional 0.5 ml of PE. (Note 18) Discard the flow-through and dry 
the column by centrifuging for another minute. Transfer the column to a fresh 
microfuge tube, add 50 l of EB to the centre of the column, leave for 1 
minute and then spin to elute the DNA. 
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11. Quantitate the gel-purified DNA by UV absorbance at 260 nm (A260). Dilute 5 
l of the gel-purified PCR product in 500 l of ddH2O, and measure the A260 
in spectrophotometer using a quartz cuvette with a ddH2O blank. Calculate the 
DNA concentration assuming that 50 g/ml gives an A260 of 1.0. Convert the 
concentration to nanomolar assuming that the molecular weight of an average 
nucleotide pair is 660 Da. (Note 19) 
12. Set up a 20 l assembly reaction by mixing 5l 4 x assembly buffer, 2 l 20 
mM DTT, gel-purified DNA fragments with terminal attP and attB sites at 2.5 
nM each, pSIRA vector at 1.25 nM and ddH2O to make a total volume of 18 
l. Start the reaction by adding 2 l of integrase diluted to 2 M in integrase 
dilution buffer (giving a final concentration of 200 nM integrase). Mix 
thoroughly (without introducing bubbles) by careful vortexing. Incubate at 30 
C for 1-24 hours. Stop the reaction by heating at 75 C for 10 minutes. (Note 
20) 
13. Use 2 l of heat-stopped reaction mix in a transformation reaction with CaCl2 
competent ccdB-tolerant cells (see sections 3.5 and 3.6) (Note 21). Spread the 
transformation reaction on LB-agar plates containing ampicillin to select for 
the SIRA vector, and incubate overnight at 37 C. 
14. Prepare plasmid DNA from several individual colonies using a QIAprep spin 
miniprep kit. Check by restriction digestion and agarose gel electrophoresis 
that the plasmids have the correct structure. Plasmids can also be verified by 
DNA sequencing. (Note 22)  
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3.4 Targeted replacement of just one segment of a multipart assembly 
This procedure follows a two-step strategy. A linear DNA molecule carrying a 
selectable marker (the chloramphenicol resistance gene) and a conditionally lethal 
gene (ccdB) (together the “CmR ccdB cassette”) flanked by appropriate attR sites is 
generated by PCR. The attR sites are chosen so as to match the attL sites flanking the 
segment to be replaced (Figure 4A). Integrase catalyzes attL x attR recombination in 
the presence of the RDF, replacing the chosen segment with the CmR ccdB cassette. 
The CmR ccdB cassette will be flanked by attP or attB sites and can be replaced in a 
standard SIRA reaction using integrase alone and a linear DNA fragment with the 
correct terminal attP or attB sites (Figure 4B). Alternatively, the CmR ccdB cassette 
can be replaced in a single reaction with multiple attP and attB cassettes (Figure 4C). 
1. Design primers to amplify the CmR ccdB cassette. These primers should 
contain attR sites at their 5’ ends that will recombine with the attL sites 
flanking the segment to be replaced. Particular care has to be taken to match 
the orientation of the attR sites and their central dinucleotides to the attL  sites 
they will recombine with. Design of these primers is illustrated in Figure 3D. 
2. Use these primers to PCR amplify the CmR ccdB cassette from p-ccdB-CmR 
following the instructions from Section 3.3, steps 4 to 6. 
3. Gel purify the resulting linear DNA fragment as described in Section 3.3, 
steps 7 to 11. 
4. Mix equal volumes of 4 M integrase and 8 M RDF in integration dilution 
buffer to make a mixture that contains 2M integrase and 4 M RDF. 
Incubate on ice for 10 minutes to allow RDF and integrase to interact. 
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5. Set up a 20 l recombination reaction in a microcentrifuge tube by mixing 5l 
4 x assembly buffer, 2 l 20 mM DTT, gel-purified PCR product containing 
the CmR ccdB cassette with terminal attR sites (4 nM final concentration) and 
plasmid DNA (12 nM final) containing the assembly in which one segment is 
to be replaced. Add ddH2O to a volume of 18 l. Start the reaction by adding 2 
l of premixed integrase and RDF and mix by vortexing. The reaction will 
contain integrase at 200 nM integrase and 400 nM RDF. Incubate at 30 C for 
2 hours and then stop the reaction by heating at 75 C for 10 minutes.  
6. Transform 2 l of the heat-stopped recombination reaction into 100 l of 
DB3.1 ccdB-tolerant CaCl2 competent cells as described in Section 3.6. 
Spread  transformation reactions on LB-agar plates containing 
chloramphenicol to select for the CmR ccdB cassette and ampicillin (or other 
antibiotic as appropriate) to select for the pSIRA vector containing the 
assembly. 
7. Prepare plasmid DNA from approximately 4 single colonies using the 
miniprep kit and verify their structure by restriction digestion and gel 
electrophoresis. Pick one plasmid sample for subsequent steps. This procedure 
will produce a plasmid containing the unchanged DNA segments, each 
flanked by a pair of attL sites, and one pair of attP and/or attB sites flanking 
the CmR ccdB cassette (Figure 4B,C). The attP and/or attB sites can be used in 
further SIRA reactions with integrase alone, while the attL sites will be 
unreactive in these conditions. 
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8. Carry out a standard SIRA reaction (Section 3.3) to replace the CmR ccdB 
cassette with one or more PCR products flanked by suitable attP and attB sites 
(Figure 4B,C). 
3.5 Preparation of competent E. coli cells  
The method given here is for “calcium chloride” chemical transformation. This 
method gives ~106 transformants per g pUC18 plasmid DNA and is adequate for all 
routine procedures described in this chapter.  
1. Streak out the appropriate E. coli strain to single colonies on an LB agar plate. 
2. Inoculate a single colony into 5 ml of LB broth and grow overnight at 37 °C, 
shaking at 225 rpm. 
3. The next day, dilute 0.4 ml of overnight culture into 20 ml of fresh LB in a 
loosely capped tube or a 50 ml conical flask with a gas-permeable stopper. 
Grow for 90 minutes at 37 °C, shaking at 225 rpm, to reach an OD600 between 
0.3 and 0.5.  
4. While the cells are growing, cool a bottle of sterile 50 mM CaCl2 by placing 
on ice. Pre-cool the centrifuge and rotor for subsequent steps. 
5. Transfer the cell culture to a 30 ml centrifuge tube and cool by placing in ice 
for 5 minutes. Take care to keep the cells as close to 0 °C as possible for the 
remainder of this procedure. 
6. Centrifuge at 6000 g (7000 rpm in a Beckmann JA20 rotor) at 4 °C for 2 
minutes. Pour away the supernatant, keeping the cell pellet. 
7. Gently resuspend the cell pellet in 10 ml of ice-cold 50 mM CaCl2 solution. 
Leave on ice for 1 hour to allow the cells to become more competent. Cells 
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can be resuspended by gently swirling the centrifuge tube, and/or pipetting up 
and down with a 10 ml pipette. 
8. Centrifuge again at 6000 g  at 4 °C for 2 minutes.  
9. Pour off the supernatant and resuspend the cell pellet in 1 ml of ice-cold 50 
mM CaCl2 solution. Store the competent cells on ice until ready for use. (Note 
23)  
3.6 Transformation of chemically competent cells 
1. Place 100 l of competent cells in a pre-cooled 1.5 ml microcentrifuge tube 
and place on ice. 
2. Add 1 l of plasmid DNA or 1-2 l of assembly reaction DNA to the cells and 
mix by gently tapping the tube. Place immediately back on ice. Control 
transformations should be done with no DNA, with a known amount of DNA 
carrying the same antibiotic resistance marker, and (for SIRA reactions) with a 
control assembly reaction from which integrase protein was omitted. 
3. Leave on ice for 30 minutes. 
4. Heat-shock by placing the tube at 42 °C for 2 minutes. 
5. Leave on ice for a further 5 minutes. 
6. Add 200 l of LB broth and incubate at 37 °C for 90 minutes to allow 
expression of the plasmid-borne antibiotic resistance gene. 
7. Use a sterile spreader to spread up to 200 l of the transformation mixture 
onto a well-dried LB agar plate containing the appropriate antibiotic, to select 
for the plasmid. (Note 24) 
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8.  Incubate the plates upside down (lids facing down) overnight (~16 hours) at 
37 C in an incubator. 
9. The next morning, count the colonies to determine transformation efficiency. 
4. Notes 
1. Antibiotic stock solutions are diluted 1000-fold into broth, or into molten agar 
at 55 °C, to obtain the working concentrations. 
2. It is best to avoid incubators with fans, as they lead to rapid desiccation of 
plates during incubation. 
3. Expression plasmids for Bxb1 and C31 integrases and RDFs are listed in 
Section 2.2. Expression plasmids for other integrases and RDFs with N-
terminal 6-His tags can be constructed in pET28(+) in essentially the same 
way. Introduce an Nde I site at the start codon of the open reading frame and 
an Asp718 / KpnI site just after the stop codon by incorporating these 
sequences into PCR primers for the desired open reading frame. Carry out 
PCR with a proofreading thermostable DNA polymerase such as Phusion. Any 
occurrences of NdeI and KpnI restriction sites within the ORF can be removed 
from the template prior to PCR by site-directed mutagenesis. Alternatively, 
coding regions can be synthesised by a commercial DNA synthesis company. 
Coding regions are then inserted between the NdeI and KpnI sites of the T7 
expression vector pET28(+). 
4. Best results are obtained if a fresh transformation is done for every protein 
expression. Storage of the expression strain on plates or as a frozen stock can 
lead to poor expression. 
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5. Induction at low temperature substantially increases the solubility of integrase 
and RDF proteins in subsequent purification steps. Higher induction 
temperature can give increased polypeptide yield, but most of the protein will 
be insoluble. 
6. It is important to wash the cells before freezing. Attempting to wash the cells 
after freezing and thawing will result in cell lysis (due to the presence of T7 
lysozyme in the BL21/DE3/plysS expression strain). 
7. It is preferable to keep cell pellets at -70 °C for long term storage. 
8. Keep the sample on ice as much as possible for this and all subsequent steps. 
In warm environments, it may be desirable to carry out these steps in a cold 
room at 4°C. 
9. Use ear protection during sonication. The sonicator can be placed in a 
soundproof cabinet. 
10. The clarified supernatant should be loaded as soon as possible onto the nickel 
affinity column. The column can be assembled onto the pump and the column 
pre-equilibrated with Buffer A (step 7 onwards) while the cells are being 
sonicated and centrifuged. 
11. We routinely run the Nickel affinity column at room temperature. However, in 
warm climates, or to avoid excessive proteolysis, results might be improved if 
the pump and column were placed in a cooled environment. 
12. A “superloop” can be used to load the protein extract onto the column. 
Alternatively, the protein solution can be loaded onto the column through the 
pump by placing the inlet tube into the container. Keep the extract on ice 
while loading by this method. Wash the inlet tube by pumping a further 10 ml 
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of Buffer A through the column from a small container, before transferring the 
now clean inlet tube back to the main bottle of Buffer A. 
13. We have found that these stock solutions retain activity better in relatively 
large volumes (greater than about 200 l in a 2 ml screw cap tube) and that 
higher-concentration stocks are more stable than low concentration stocks. 
14. Use the “Santa Lucia 1998” setting for the Table of thermodynamic 
parameters for calculating the Tm in Primer3. 
15. Dimethyl sulphoxide (DMSO), MgCl2 solution and 5x HF buffer are supplied 
along with the enzyme by the manufacturer (New England Biolabs). The 
template can be ~1 ng plasmid DNA, or ~10 ng chromosomal DNA containing 
the gene to be amplified. We routinely dilute 1 l of plasmid miniprep DNA in 
100 l of ddH2O and use 1 l of this diluted DNA as template for PCR 
reactions. Alternatively, use 1 l of bacterial chromosomal DNA (~100 ng / 
l) diluted 1 in 10 in ddH2O, or suspend a bacterial colony in 100 l of ddH2O 
and use 1 l, or use 1 l of diluted PCR product (~ 1 ng/l). 
16. We use an Eppendorf minicycler set on “block control” for these PCR 
reactions. Reactions can be carried out overnight and products will remain 
stable at 4 C when the PCR is complete. The 2 minute elongation time can be 
adjusted according to the length of PCR product expected, with a minimum of 
approximately 1 minute per kbp. 
17. The 2 l and 48 l samples can be run at the same time on two halves of the 
same gel. Stain both together, photograph the 2 l samples to check the PCR 
has worked correctly and then excise the 48 l DNA samples from the other 
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half of the gel. Make sure not to expose the part of the gel containing the 48 l 
samples to short-wave UV to avoid damaging the DNA. 
18. This additional wash with PE removes remaining traces of guanidinium (from 
buffer QG) that would otherwise interfere with quantitation of DNA by UV 
absorbance at 260 nm. 
19. The relative concentrations of DNA can be determined by gel electrophoresis 
instead. This is sufficient for most assembly reactions. The aim is to have 
equimolar amounts of the PCR products and a slight excess over the pSIRA 
vector. Run 2 l samples of each-gel purified PCR product on a 1% agarose 
gel adjacent to a DNA molecular weight marker of know concentration. Stain 
the gel with ethidium bromide and photograph using a BioRad Gel Doc™ 
system. Quantitate the bands to obtain relative intensities using the “volume 
rectangle” tool in the Gel Doc software, using local background correction to 
subtract the background level from a blank part of the gel. Calculate the 
concentration of purified PCR product using the following formula: 
concentration = (volume of known standard loaded on gel (l) x size of 
standard (bp) x volume % of sample (from quantitation)) /  (volume of 
unknown sample loaded on gel (l) x size of unknown band (bp) x Volume % 
of standard (from quantitation)). 
20. More than one integrase can be added to the assembly reaction at the same 
time if att sites from different integrases are being used. Each integrase should 
be at a final concentration of 200 nM. The more fragments being assembled, 
the longer the incubation needs to be. Inserting a single fragment into a pSIRA 
vector gives many colonies after just 1 hour, 3 fragments requires about 4 
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hours to achieve similar numbers of colonies, whereas 5 fragments with a 
single integrase requires a 24 hour reaction.) 
21. Any other transformation method works at this stage. Commercially prepared 
chemically competent cells can be used. To produce large libraries by 
combinatorial assembly, we recommend electroporation. The DNA must be 
precipitated with ethanol and dissolved in ddH2O prior to electroporation, to 
remove ions that would interfere with the electroporation procedure. To 
ethanol-precipitate the DNA, add one ninth of the original volume of 3 M 
sodium acetate solution and 2.2 volumes of 100% ethanol. Mix thoroughly, 
incubate for at least 30 minutes at -20 C, then centrifuge at full speed in a 
microcentrifuge for 20 minutes at 4 C. Wash the pellet in 500 l of 70% 
ethanol. After pouring off the 70% ethanol, spin down any remaining ethanol 
and remove all remaining traces with a pipettor attached to a 200 l pipette tip. 
Allow the pellet to air-dry at room temperature with the tube lid open for 5 
minutes, and then resuspend the DNA in 10 l of ddH2O. Use 1 l of this 
ethanol precipitated DNA in a standard electroporation method. 
22. For libraries produced by combinatorial assembly, wash all of the 
transformant colonies off the plate in 5 ml of LB broth, resuspending 
thoroughly using a glass spreader and by pipetting up and down. Library DNA 
can be purified directly using a miniprep kit on a suitable (~0.5 ml) sample of 
this cell suspension. 
23. Competent cells can be stored at 0 °C for up to 48 hours. They increase in 
competence for at least the first 24 hours. 
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24. Plates can be dried by leaving them with their lids off in a laminar flow hood 
for approximately 20 minutes, or upside down with lids off in a well ventilated 
incubator at 37 C for about 30 minutes. 
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Figure Legends 
 
Figure 1. Recombination by large serine integrases can be used to join DNA 
fragments. A. The natural function of these proteins is to integrate the circular 
bacteriophage DNA into the host genomic DNA. Integrase catalyzes recombination 
between an attP site on the phage DNA and an attB site on the host DNA. The 
integrated phage DNA is flanked by attL and attR sites. Recombination between attL  
and attR requires the phage encoded RDF protein in addition to integrase. B. Top and 
bottom strand sequences of 46 bp wild-type C31 attP and attB sites. The staggered 
lines indicate the positions of cleavage either side of the central TT/AA dinucleotide. 
C. Recombination between an attP site on the end of one DNA fragment and an attB 
site on the end of a second DNA fragment joins the two fragments together, releasing 
an attR site. The joined fragments will be separated by an attL “scar” sequence. D. By 
changing the central dinucleotides of the att sites, six different “orthogonal” attP-attB 
pairs can be created that recombine only as matching pairs. Symmetric dinucleotides 
(AT, TA, GC and CG) should be avoided as they allow recombination in either 
orientation. Sites with the reverse complement of the sequences shown should also be 
avoided as they are not orthogonal; for instance attP with TT on the top strand 
recombines efficiently with  attB with AA on the top strand. 
 
Figure 2. Strategies for assembling DNA fragments into pSIRA. A. pSIRA vectors 
contain two orthogonal attB sites (with TT and TC central dinucleotides) flanking the 
conditionally lethal ccdB gene (red). Integrase catalyzes a cassette exchange reaction, 
replacing the ccdB gene with the fragment of interest (blue line). B-D Strategies for 
assembling three, four or five DNA fragments into a linear fragment that can be 
inserted into the pSIRA vector in the same reaction. Linear DNA fragments are mixed 
with the pSIRA vector and assembled into the plasmid in a “one-pot” reaction. E. 
Assembly using two integrases. The diagram shows how Bxb1 integrase and C31 
integrase can be used to assemble seven DNA fragments into pSIRA in a “one-pot” 
reaction. 
 
Figure 3. Generation of linear fragments for SIRA reactions by PCR. A. att sites can 
be added to the ends of linear DNA fragments by addition at the 5’ end of PCR 
primers. Ribosome binding sites (RBS) for efficient translation initiation in bacterial 
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systems can also be added to open reading frames (ORFs). B. Examples of primers 
used to add C31 att sites to PCR products for SIRA assembly reactions (taken from 
reference [10]).  The different parts of the primers are indicated by different colours 
above the sequence. Starting from the 5’ end primers include a 4-8 nucleotide 
sequence so that the att site is not too close to the end of the DNA fragment (grey), 
attP (yellow) or attB (cyan) sites with the central dinucleotides highlighted (red) and 
underlined, a RBS for forward primers (green and underlined), start codon (dark 
blue), stop codon (pink), and a region homologous to the template DNA (light blue). 
Note that the reverse complement of att sites and their central dinucleotides are 
incorporated into primers containing  attB. C. Sequences of Bxb1 attP and attB sites 
that can be added to primers for SIRA reactions with Bxb1 integrase. D. Primers to 
add attR sites to the ccdB-CmR cassette. The attP (yellow) and attB (cyan) half sites 
that make up attR are indicated along with the central dinucleotide (red) above the 
sequence. Care should be taken to use the correct orientation and central dinucleotide 
of attR to match the attL sites being targeted. 
 
Figure 4. SIRA assemblies can be modified by further recombination reactions. A. A 
linear DNA fragment carrying the ccdB and CmR genes flanked by attR sites is 
generated by PCR. Care must be taken to ensure that the attR sites are in the correct 
orientation and have the correct central dinucleotides to recombine with the chosen 
attL sites in the assembly. Recombination with integrase in the presence of RDF 
replaces one or more parts of the assembly with the ccdB-CmR cassette. Reaction 
mixes are transformed into a ccdB-tolerant E. coli strain, and CmR transformants are 
selected. B-C. The ccdB-CmR cassette can be replaced with one (B) or more (C) DNA 
fragments using standard SIRA reactions with just integrase. Plasmids lacking the 
ccdB gene are selected by transformation into a ccdB sensitive E. coli strain. 
Fragments in the original assembly are labelled 1 to 5. In (B) fragment 3 is replaced 
by fragment 3*. In (C) fragment 4 is replaced by fragments 6,7, and 8. 
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